Stock Evaluator: Park Ha Biological Technology Co., Ltd. (BYAH)
Park Ha Biological Technology Co., Ltd. BYAH
$2.70
-0.08
-2.88%
September 2, 2026 4:00:00 PM
EST
Volume: 11,244
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Consumer Discretionary | Specialty Retail |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People’s Republic of China. It operates in two segments, Product Sales and Franchise Service. The company offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company has a strategic partnership with Star Plus Action (HK) Limited to build an AI-powered skincare and health ecosystem and expand its healthcare reach. Park Ha Biological Technology Co., Ltd. has strategic partnership with Cloud Factory Technology Holdings Limited to build ai-driven ecosystem for the beauty industry. The company was founded in 2016 and is headquartered in Wuxi, the People’s Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.
Financial Summary
| Share Statistics | BYAH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2.0 | $965.1 | 1% |
|
| Shares Out (Mil) | 0.4 | 47.6 | 2% |
|
| Institutional Ownership | 2.4% | 75.9% | 3% |
|
| Float (Mil) | 0.4 | 33.6 | 1% |
|
| Beta | na | 1.13 | na |
|
| Avg Daily Volume (000s) | 57 | 257 | 30% |
|
| Price Change (52-week) |
(98.7%) | 67.7% | 1% |
|
| Growth | BYAH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.8% | na |
|
| Net Income (5yr) | na | 8.2% | na |
|
| EPS (5yr) | na | 13.0% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (16.1%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | BYAH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3 | $1,999 | 4% |
|
| Net Income (TTM) (Mil) | ($5) | $38 | 33% |
|
| EPS (TTM) | ($25.326) | $0.500 | 2% |
|
| Operating Cash Flow (TTM) (Mil) | $-0 | $115 | 32% |
|
| Net Cash Flow (TTM) (Mil) | ($1) | $1 | 40% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $446 | 10% |
|
| Enterprise Value (Q1) (Mil) | ($3) | $1,749 | 2% |
|
| Valuation | BYAH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.31 | 1.71 | 4% |
|
| P/E | na | 18.1 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | BYAH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 94.9% | 38.7% | 95% |
|
| Net Margin | (214.2%) | 1.9% | 4% |
|
| ROA | (82.0%) | 2.8% | 7% |
|
| ROE | (113.0%) | 10.5% | 8% |
|
| Liabilities to Assets | 27.8% | 68.2% | 19% |
|
| F-Score | 4 | 5 | 33% |
|
Park Ha Biological Technology Co., Ltd. did not pass any screens on 9/2/2026.
